Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
FDA Warns Public Against Using Hydroxychloroquine or Chloroquine To Treat COVID-19 April 27, 2020 Martha Garcia Add Your Comments Federal regulators urge consumers not to take hydroxychloroquine and chloroquine outside of a hospital setting for COVID-19, following weeks of speculation and hope the malaria drugs may be potential coronavirus treatments. In a drug safety communication issued on April 24, the FDA warned the public to avoid buying or using hydroxychloroquine and chloroquine. The two drugs should only be used in a hospital setting, when prescribed by a doctor or in clinical trials. Hydroxychloroquine and chloroquine are increasingly being used inappropriately to treat non-hospitalized patients with COVID-19, even though there is no evidence the drugs work to treat or prevent coronavirus, and may result in serious or life-threatening side effects. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION President Donald Trump has advocated strongly in recent weeks for the use of hydroxychloroquine to treat COVID-19, prompting many people to attempt using the drug on their own, without a prescription or supervision of a doctor or healthcare facility. Currently, hydroxychloroquine and chloroquine are approved to treat malaria and autoimmune conditions like lupus and rheumatoid arthritis. The drugs are being studied in clinical trials and the FDA authorized the temporary use of hydroxychloroquine and chloroquine during the COVID-19 pandemic under limited circumstances, but not through regular FDA approval. The FDA authorized the temporary use of hydroxychloroquine and chloroquine only in hospitalized patients with COVID-19 when clinical trials are not available. The use of the drugs outside of hospitalized settings for coronavirus is not approved by the agency. The temporary FDA approval is for patients who test positive for COVID-19 and are being treated in the hospital or are enrolled in a clinical trial. However, in several studies so far, researchers have linked the two drugs to serious side effects, including potentially fatal heart rhythm problems. One recent study on hydroxychloroquine was stopped early after too many patients developed irregular heart rates. Patients taking a higher dose began developing irregular heart rates within three days of taking the drug. Another study of hydroxychloroquine use among Veterans infected with COVID-19 concluded patients who took the drug had a higher rate of death compared to patients who did not use the drug. The FDA also reviewed case reports from the Adverse Event Reporting System database and found reports of abnormal heart rhythms, dangerously rapid heart rates, and in some cases death. Other risks arise when the drugs are combined with the antibiotic azithromycin, more commonly known as Zithromax or Z-pak. The FDA is reviewing the safety of the use of hydroxychloroquine and chloroquine outside of the hospital setting. However, to date it has not been shown to be safe or effective to treat COVID-19 outside of a doctor’s care. Currently, the agency warns the drugs should only be used for COVID-19 when recipients can be appropriately monitored in the hospital, or the patient is enrolled in a clinical trial with adequate follow up screening and monitoring. Even when prescribed by a doctor hydroxychloroquine and chloroquine should be used with extreme caution, especially among patients who have other health issues, such as heart and kidney disease, the FDA warns. The agency urges consumers not to buy the drugs from online pharmacies without a prescription from a doctor. There is no proven treatment for COVID-19 and no vaccine for the disease. If you receive hydroxychloroquine and chloroquine and experience side effects such as irregular heartbeat, dizziness, or fainting, call 911 and get medical attention right away and notify the FDA’s Adverse Event Reporting System. Tags: Antibiotic, Azithromycin, Chloroquine, Clinical Trials, Coronavirus, Heart Rhythm, Hydroxychloroquine, Infection, Malaria, Zithromax Image Credit: | More Lawsuit Stories MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 May 16, 2025 Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study May 16, 2025 Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor May 15, 2025 2 Comments Margaret August 4, 2021 I was prescribed hydroxychloroquine to treat Sjogren’s Syndrome and took it for several years. During this time I could not read for long periods of time without my vision becoming blurry. When mentioning this to various Ophthalmologists I was seeing, I was told it was because I wasn’t blinking enough. All were made aware of my taking hydroxychloroquine for Sjogren’s. I think they all thought I was a crazy old lady. Well, when I had to see a retina specialists the first thing she did was tell me to stop taking the drug immediately. It had already caused problems with the macula. Since stopping I am able to read for longer periods without blurring and I don’t believe I am blinking any more than I did before. I have since found out that there are problems with my kidneys which research tells me can be caused by hydroxychloroquine. I do recall reading some of these warnings when it was first prescribed but the prescribing doctor told me the side effects were very rare and I should take the medicine. I wish I had listened to my gut and not my doctor. Hydroxychloroquine is a dangerous medication and I also believe the FDA should put a severe warning on this medication for all uses, not just for Covid-19. Sharon May 28, 2021 I was on hydroxochloriquine for Lupus and after 4 plus weeks at 2 pills a day my legs are totally numb and I am unable to walk. I cannot even walk to the car and cannot get to a doctor and will have to hire an ambulance to transport me to a hospital. The doctor had me on this for Lupus and I finally stopped the hydroxoychloroquine and the pain and numbness in my legs is starting the subside. While on this med I have never had such excruciating pain in my life. My blood work came back very good but with the highest number for RA. I think this medication is very dangerous and I will seek an attorney for the FDA not putting a severe warning on this medication. I am 73 years old and unable to get pain pills because the FDA has such restrictions o those but they have no restrictions on Hydroxychloroquine. This is inexcusable for the FDA too do to any senior. This forces any senior to suffer horribly needlessly all due o the FDA not allowing pain pills to be given to us. Why the hell is the FDA thinking? I know they are wanting all seniors to die but I am not going away. Hydroxychloroquine is a dangerous medication. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: today) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: yesterday) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 2 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor May 15, 2025
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: today) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: yesterday) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 2 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)